You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apg-1252

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

Withdrawn
  • Myelofibrosis
  • Gilbert, Arizona
  • +1 more
Jul 8, 2022

NHL, Adult Trial in Zhengzhou, Shanghai, Nanyang (APG-1252, Chidamide)

Recruiting
  • NHL, Adult
  • Zhengzhou, Henanan, China
  • +3 more
Jul 27, 2022

Small Cell Lung Cancer Trial in Australia, United States (APG-1252, Paclitaxel)

Terminated
  • Small Cell Lung Cancer
  • Plantation, Florida
  • +7 more
Jul 8, 2022

EGFR Positive NSCLC Trial in China (APG-1252, Osimertinib Mesylate Tablets)

Recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • APG-1252
  • Osimertinib Mesylate Tablets
  • Guangzhou, Guangdong, China
  • +3 more
Oct 27, 2021

Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)

Terminated
  • Small Cell Lung Cancer and Other Solid Tumors
  • APG-1252
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 24, 2021